Although the cGMPs are designed to ensure products are safe from a standpoint of identity, purity, quality, strength and composition, they do not address preclinical or clinical testing of ingredients for safety or efficacy.
Regular sunscreen use has the benefit of evening skin tone and preventing wrinkles, so applying sunscreen with high SPF on your face may go a long way toward replacing face creams that contain ingredients of dubious safety for your baby.
Jennifer Kuzma discussed attitudes toward foods with genetically modified and nanotechnology ingredients and expectations of safety, a concept that cannot be based solely on science, but includes the values of the community setting safety standards.
Customer Feedback – Ingredients, high levels of safety and effectiveness, and incredible value are worthless if the customers who have used the product are not happy with it!
Manufacturers would be required to register each year with the FDA and furnish documentation of ingredient safety through testing and expert analysis.
According to the safety assessment of the ingredients, 1,5-pentanediol was an ingredient of special concern since its margin of safety was below the threshold of 100 (36.53).
Chemical alteration of an ingredient is presumed to alter its biologic behavior and hence a separate safety assessment is required to establish reasonable expectation of safety or that the altered ingredient is comparable to the native ingredient in relevant characteristics.
There are ingredients of special concern in terms of safety assessment like preservatives, solubilizers, and surfactants.
This implies the need of safety assessment for all ingredients of cosmetic products, and the need to employ appropriate models to test chemical ingredients for their potential to cause skin irritation and sensitization, as well as genotoxic damage.
In addition to the possibility of ingredient-specific safety concerns, mascara and other cosmetic eyelash enhancers carry a risk of bacterial and fungal contamination and subsequent infection in addition to a risk of conjunctival pigmentation [ 7].
At the same time, the committee concluded that "comparisons of the pharmacokinetics of single-ingredient products versus multiple ingredient products" and "safety evaluations of the effects of phenylephrine on blood pressure and cardiovasculature and use of phenylephrine in patients with important comorbidities such as BPH, hypertension or diabetes mellitus" be conducted [ 45].
